Literature DB >> 3294006

Immunogold localization of circumsporozoite protein of the malaria parasite Plasmodium falciparum during sporogony in Anopheles stephensi midguts.

G Posthuma1, J F Meis, J P Verhave, M R Hollingdale, T Ponnudurai, J H Meuwissen, H J Geuze.   

Abstract

The occurrence of the circumsporozoite (CS) proteins of Plasmodium falciparum sporozoites was monitored during sporogonic development in Anopheles stephensi mosquitoes. Using a monoclonal anti-CS protein antibody (3Sp2) and immunogold labeling on ultrathin cryosections it was found that CS protein is synthesized in immature oocysts from day 6 onwards when there are not yet signs of sporozoite formation. The CS protein is rapidly incorporated in the oocyst plasmalemma, which subsequently invaginates into the parasite. In the oocyst only the external sporozoite membrane contains CS protein. The inner pellicle membranes, rhoptries and micronemes do not react with monoclonal antibody (MoAb) 3Sp2.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3294006

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  13 in total

1.  Localization of circumsporozoite protein in the sporogonic stages of Plasmodium vivax.

Authors:  J F Meis; H Croes; B Mons; A van Belkum; T Ponnudurai
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

2.  Localization of CS and non-CS antigens in the sporogonic stages of Plasmodium yoelii.

Authors:  M Aikawa; C T Atkinson; L M Beaudoin; M Sedegah; Y Charoenvit; R Beaudoin
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

3.  Levels of circumsporozoite protein in the Plasmodium oocyst determine sporozoite morphology.

Authors:  Vandana Thathy; Hisashi Fujioka; Soren Gantt; Ruth Nussenzweig; Victor Nussenzweig; Robert Ménard
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

4.  Plasmodium falciparum ookinetes migrate intercellularly through Anopheles stephensi midgut epithelium.

Authors:  J F Meis; G Pool; G J van Gemert; A H Lensen; T Ponnudurai; J H Meuwissen
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

5.  Roles of the amino terminal region and repeat region of the Plasmodium berghei circumsporozoite protein in parasite infectivity.

Authors:  Cassandra Aldrich; Alessandro Magini; Carla Emiliani; Tania Dottorini; Francesco Bistoni; Andrea Crisanti; Roberta Spaccapelo
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

6.  Exit of Plasmodium sporozoites from oocysts is an active process that involves the circumsporozoite protein.

Authors:  Qian Wang; Hisashi Fujioka; Victor Nussenzweig
Journal:  PLoS Pathog       Date:  2005-09-30       Impact factor: 6.823

7.  Release of Plasmodium sporozoites requires proteins with histone-fold dimerization domains.

Authors:  Chiara Currà; Renate Gessmann; Tomasino Pace; Leonardo Picci; Giulia Peruzzi; Vassiliki Varamogianni-Mamatsi; Lefteris Spanos; Célia R S Garcia; Roberta Spaccapelo; Marta Ponzi; Inga Siden-Kiamos
Journal:  Nat Commun       Date:  2016-12-16       Impact factor: 14.919

8.  Effect of chloroquine on gene expression of Plasmodium yoelii nigeriensis during its sporogonic development in the mosquito vector.

Authors:  Henrique Silveira; Susana Ramos; Patrícia Abrantes; Luís Filipe Lopes; Virgílio E do Rosario; Mitchell S Abrahamsen
Journal:  Malar J       Date:  2007-07-02       Impact factor: 2.979

9.  Differing patterns of selection and geospatial genetic diversity within two leading Plasmodium vivax candidate vaccine antigens.

Authors:  Christian M Parobek; Jeffrey A Bailey; Nicholas J Hathaway; Duong Socheat; William O Rogers; Jonathan J Juliano
Journal:  PLoS Negl Trop Dis       Date:  2014-04-17

10.  Effect of ingested human antibodies induced by RTS, S/AS01 malaria vaccination in children on Plasmodium falciparum oocyst formation and sporogony in mosquitoes.

Authors:  Kazutoyo Miura; Erik Jongert; Bingbing Deng; Luwen Zhou; John P Lusingu; Chris J Drakeley; Michael P Fay; Carole A Long; Johan Vekemans
Journal:  Malar J       Date:  2014-07-09       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.